NasdaqGS - Nasdaq Real Time Price USD

Spyre Therapeutics, Inc. (SYRE)

16.62
+0.10
+(0.61%)
At close: June 5 at 4:00:01 PM EDT
All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-169,862
-157,410
-99,910
-80,144
-53,716
Investing Cash Flow
-248,383
-353,285
-108,393
57,008
-22,619
Financing Cash Flow
238,866
410,906
361,077
42,678
1,393
End Cash Position
48,492
89,423
189,215
36,416
16,980
Capital Expenditure
--
--
--
-38
-573
Issuance of Capital Stock
236,027
405,232
366,474
42,874
0
Repayment of Debt
--
0
-16
-418
-510
Free Cash Flow
-169,862
-157,410
-99,910
-80,182
-54,289
12/31/2021 - 4/7/2016

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ORKA Oruka Therapeutics, Inc.
12.19
+4.37%
 
CNTA Centessa Pharmaceuticals plc
11.86
-5.35%
 
UPB Upstream Bio, Inc.
10.83
-0.28%
 
XNCR Xencor, Inc.
9.12
+0.22%
 
XENE Xenon Pharmaceuticals Inc.
30.73
+0.89%
 
PHVS Pharvaris N.V.
16.05
-3.43%
 
CRNX Crinetics Pharmaceuticals, Inc.
32.32
+0.59%
 
APGE Apogee Therapeutics, Inc.
37.65
+3.15%
 
COGT Cogent Biosciences, Inc.
5.99
+6.21%
 
JBIO Jade Biosciences, Inc.
6.89
-4.44%